Bio-FD&C Co

Bio-FD&C Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Bio-FD&C Co (251120.KQ) as of Nov 16, 2026 is 1.15. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.70 — a change of -32.48% (lower).

PEG

1.15

YoY

-32.48%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Bio-FD&C Co is 2025 1.15 . PEG Ratio (Price/Earnings-to-Growth) of Bio-FD&C Co was 2024 1.70 . It decreases by -32.48% lower compared to the previous year.

The Bio-FD&C Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
18.99 KRW
Jan 1, 2019
2.99 KRW
Jan 1, 2020
3.12 KRW
Jan 1, 2021
2.64 KRW
Jan 1, 2022
1.77 KRW
Jan 1, 2023
1.37 KRW
Jan 1, 2024
1.70 KRW
Jan 1, 2025
1.15 KRW
The Bio-FD&C Co PEG history
YEARPEGYoY
1.15-32.48%
1.70+24.09%
1.37-22.38%
1.77-32.93%
2.64-15.34%
3.12+4.08%
2.99-84.23%
18.99—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

PEG Ratio (Price/Earnings-to-Growth) of Bio-FD&C Co is 1.15 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Bio-FD&C Co changed from 1.70 to 1.15, representing a -32.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co